首页> 外文OA文献 >Discovery and development of inhibitors selective for human constitutive proteasome and immunoproteasome active sites
【2h】

Discovery and development of inhibitors selective for human constitutive proteasome and immunoproteasome active sites

机译:发现和开发对人组成型蛋白酶体和免疫蛋白酶体活性位点有选择性的抑制剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This thesis describes the design and development of subunit‐selective inhibitors of particular catalytically active subunits of human constitutive proteasomes and immunoproteasomes. Most existing proteasome inhibitors are oligopeptides composed of 2‐4 amino acid residues, N‐terminally capped and with the C‐terminus adapted to give an electrophilic trap. Such compounds are also at the basis of the research described in this Thesis. Attention was directed to substitute specific amino acid residues by either synthetic, non‐canonical amino acid derivatives (with a review on the synthesis of such items given in Chapter 2) or dipeptide isosteres. Alternatively, modifications of the electrophilic trap, specifically, the epoxyketone moiety, were investigated. In this way, and by the synthesis of focused libraries, in which in each case a number of structural analogues, rather than a single one, inhibitors selective for β5c, β2c and β2i were discovered, and a number of two‐step activity‐based probes for probing these activities in vitro and in situ were identified.
机译:本文描述了人类组成型蛋白酶体和免疫蛋白酶体特定催化活性亚基的亚基选择性抑制剂的设计和开发。大多数现有的蛋白酶体抑制剂是由2–4个氨基酸残基组成的寡肽,其N端被封端,并且C末端适于形成亲电陷阱。这些化合物也是本论文所述研究的基础。人们关注用合成的非规范氨基酸衍生物(在第2章中对这类物质的合成进行综述)或二肽等位基因来替代特定的氨基酸残基。可替代地,研究了亲电子阱,特别是环氧酮部分的修饰。通过这种方式,并通过集中的文库的合成,在每种情况下,许多结构类似物,而不是单个结构类似物,被发现对β5c,β2c和β2i具有选择性的抑制剂,以及许多基于两步活性的抑制剂。鉴定了用于在体外和原位探测这些活性的探针。

著录项

  • 作者

    Xin B.;

  • 作者单位
  • 年度 2017
  • 总页数
  • 原文格式 PDF
  • 正文语种
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号